Amgen is hiring an Associate Full Stack Engineer to support the design, development, and maintenance of high-quality software applications that address complex business needs. As part of the development team, you will work alongside senior engineers and cross-functional teams including product managers and designers. This role involves both front-end and back-end development responsibilities and requires a strong foundation in cloud technologies and modern software practices.
This role may require working in later hours and could include second or third shift schedules based on business needs. Candidates must be open to working evening or night shifts as required.
Amgen offers a collaborative, innovative, and science-driven environment with a strong focus on personal and professional growth. Along with a competitive base salary, you will receive comprehensive Total Rewards aligned with local standards. You will contribute to a mission that impacts millions of lives and have the opportunity to grow your career in a globally recognized biotechnology company.
Python, JavaScript, SQL, NoSQL, API Integration, Microservices, Serverless Architecture, Docker, Kubernetes, AWS, Azure, GCP, Prometheus, Grafana, Splunk, Hadoop, Spark
If an employer asks you to pay any kind of fee, please notify us immediately. Talentd does not charge any fee from applicants and we do not allow other companies to do so.
Amgen Inc. is a leading multinational biotechnology company headquartered in Thousand Oaks, California, USA. Founded in 1980, Amgen is dedicated to discovering, developing, manufacturing, and delivering innovative human therapeutics. Its mission is to serve patients by transforming scientific discoveries into medicines that improve lives, with a focus on areas such as oncology, cardiovascular disease, neuroscience, and inflammation. The company is recognized for pioneering biologics and leveraging advanced genetic research to address serious illnesses.
With over 25,000 employees worldwide, Amgen holds a strong position in the global biotech market, consistently ranking among the largest biotechnology firms by revenue. It has a diverse portfolio of approved medicines, including well-known biologics like Enbrel, Neulasta, and Prolia, as well as a robust pipeline of investigational therapies. Recently, Amgen has made headlines for strategic acquisitions, such as its purchase of Horizon Therapeutics in 2023, expanding its rare disease portfolio, and for advancing cutting-edge research in biosimilars and precision medicine. The company is also committed to sustainability and corporate responsibility, aiming to reduce its environmental footprint while maintaining high standards of scientific excellence.
Websiteamgen.com
